Jeffrey B. Washam

Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative

Trip J. Meine, Matthew T. Roe, Anita Y. Chen et al. · American Heart Journal · 2005 · 303 citations

Opioid Epidemic, Harm Reduction, Cardiovascular Disease +14

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial

Sean D. Pokorney, Glenn M. Chertow, Hussein R. Al‐Khalidi et al. · Circulation · 2022 · 203 citations

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

Jeroen Jaspers Focks, Marc A. Brouwer, Daniel Wojdyla et al. · BMJ · 2016 · 179 citations · Full text

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation

Jonathan P. Piccini, Anne S. Hellkamp, Jeffrey B. Washam et al. · Circulation · 2015 · 172 citations · Full text

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Jeffrey B. Washam, Susanna R. Stevens, Yuliya Lokhnygina et al. · The Lancet · 2015 · 143 citations

Thrombosis, Digoxin Use, Cardiovascular Disease +13